Lei Xu

机构：Dalian Medical University, The First People’s Hospital of Lianyungang · ORCID：0000-0002-3573-8334

发表论文 190 篇 · 总被引 4017 次 · h-index 28

代表论文

• A dual chemodrug-loaded hyaluronan nanogel for differentiation induction therapy of refractory AML via disrupting lysosomal homeostasis (2025 · Science Advances · 被引 19)
• Latent normal images-based zero-negative sample rail surface defect segmentation method (2025 · Automation in Construction · 被引 9)
• IDDF2025-ABS-0172 Association between the triglyceride glucose-body mass index and cardiovascular-kidney-metabolic syndrome risk in chronic liver disease: a nationwide prospective cohort study (2025 · 被引 6)
• From genes to therapy: a lipid Metabolism-Related genetic risk model predicts HCC outcomes and enhances immunotherapy (2025 · BMC Cancer · 被引 6)
• SUCLG1 deficiency-induced histone succinylation impairs oncogene expression in acute myeloid leukemia (2025 · Cell Reports · 被引 5)
• Multimorbidity is significantly associated with higher prevalence of depressive symptoms in middle-aged and older Chinese adults (2025 · Preventive Medicine Reports · 被引 4)